Clinical trial
Effects and Safety Evaluation of Changes in Cognitive Function of Photobiomodulation Treatment for Patients With Mild Cognitive Impairment (MCI): Single-institutional Prospective Clinical Trial, Single Group, Pilot Trial
NCT04721093 is registered in ClinicalTrials.gov with Pusan National University Yangsan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects and Safety Evaluation of Changes in Cognitive Function of Photobiomodulation Treatment for Patients With Mild Cognitive Impairment (MCI): Single-institutional Prospective Clinical Trial, Single Group, Pilot Trial
- Lead sponsor
- Pusan National University Yangsan Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 12, 2019
- Completion date
- June 30, 2020
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cognitive function, mild cognitive impairment, regional cerebral blood flow